Medicare Enrolled

Dr. Raisa Epistola, M.D.

Q: Does Dr. Epistola receive payments from pharmaceutical companies?

Yes. Dr. Epistola received a total of $1,590 from 23 companies across 46 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Epistola) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Hematology & Oncology · Everett, WA

1717 13TH ST, Everett, WA 98201

4252975560

Registered in NPPES since 2017

NPI: 1417482910 verify on NPPES ↗

Moderate

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Epistola from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Epistola? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Epistola

Dr. Raisa Epistola is a hematology & oncology specialist in Everett, WA, with 9 years of NPI registration.

Between the years covered by Open Payments, Dr. Epistola received a total of $1,590 from 23 pharmaceutical and/or device companies across 46 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Epistola is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years of NPI registration $1,590 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$1,590

Total received (2020-2024)

Avg $318/year across 5 years

Top 41% in WA for hematology & oncology

A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.

Companies

Payment records

Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$476

2023

$87

2022

$573

2021

$381

2020

$72

Payments by company (2024)

Exelixis Inc.

$174

EMD Serono, Inc.

$73

SpringWorks Therapeutics, Inc.

$40

Regeneron Healthcare Solutions, Inc.

$38

PharmaEssentia USA Corporation

$34

Astellas Pharma US Inc

$33

Pharmacosmos Therapeutics Inc.

$24

Blueprint Medicines Corporation

$23

Mirati Therapeutics, Inc.

$20

E.R. Squibb & Sons, L.L.C.

$16

Top 3 companies account for 60.2% of 2024 payments

All-time payments by company (2020-2024) ›

Regeneron Healthcare Solutions, Inc.

$353

Exelixis Inc.

$194

Celgene Corporation

$153

Seagen Inc.

$124

EMD Serono, Inc.

$100

Karyopharm Therapeutics Inc.

$84

GENZYME CORPORATION

$62

Incyte Corporation

$56

Takeda Pharmaceuticals U.S.A., Inc.

$53

Alexion Pharmaceuticals, Inc.

$42

SpringWorks Therapeutics, Inc.

$40

PharmaEssentia USA Corporation

$34

E.R. Squibb & Sons, L.L.C.

$34

Astellas Pharma US Inc

$33

Amgen Inc.

$32

Kite Pharma, Inc.

$30

Stemline Therapeutics Inc.

$26

Lilly USA, LLC

$25

AstraZeneca Pharmaceuticals LP

$24

Pharmacosmos Therapeutics Inc.

$24

Daiichi Sankyo Inc.

$23

Blueprint Medicines Corporation

$23

Mirati Therapeutics, Inc.

$20

Top 3 companies account for 44.0% of all-time payments

Associated products mentioned in payments ›

ADCETRIS · AYVAKIT · BESREMI · Blincyto · CABOMETYX · COSELA · ELITEK · ELZONRIS · ENHERTU · ENJAYMO · IMFINZI · JAKAFI · KRAZATI · LIBTAYO · OGSIVEO · OPDIVO · Pomalyst · REBLOZYL · TIVDAK · TUKYSA · Ultomiris · VERZENIO · XPOVIO · Xospata

Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Looking for a hematology & oncology specialist in Everett?
Compare hematology & oncology specialists in the Everett area by procedure volume, costs, and industry payment transparency.

Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas

County median income

$107,982

Nearest hospital to ZIP centroid (approximate)

PROVIDENCE REGIONAL MEDICAL CENTER EVERETT
0.0 mi

Data Sources

Provider Registry	✓ NPPES	NPPES snapshot; verify current record
Medicare Enrollment	✓ PECOS	PECOS snapshot
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not included	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Epistola is a hematology & oncology specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Epistola receive payments from pharmaceutical companies?

Yes. Dr. Epistola received a total of $1,590 from 23 companies across 46 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Epistola) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city

Hematology & Oncology Specialists in Everett

Browse hematology & oncology specialists in Everett ranked by procedure volume and transparency data.

Highest volume

Top Hematology & Oncology Specialists in WA

Hematology & oncology specialists ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Hematology & Oncology Specialists in WA

Which WA hematology & oncology specialists receive the most from drug and device companies.

By company

Regeneron Healthcare Solutions, Inc. Payments to Doctors

See all physicians who received payments from Regeneron Healthcare Solutions, Inc.

By company

Exelixis Inc. Payments to Doctors

See all physicians who received payments from Exelixis Inc.

By company

Celgene Corporation Payments to Doctors

See all physicians who received payments from Celgene Corporation.

About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology